Chronicling the COPD Patient Journey and Change in COPD Symptoms, Quality of Life and Exacerbations Following Initiation of Budenoside/Glycopyrronium/Formoterol [BGF]

Clinical trial NCT06511193 · COMPLETED

Trial details

NCT number: NCT06511193
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2024-09-17
Primary completion: 2026-05-05
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.